Because we know you have busy lives (along with a lot of basketball to watch) we have condensed for you some of our favorite posts from the first two weeks of March.
In this installment, we look at the impact that the iPad 3 will have on medicine, ways for you to take an idea for a healthcare app and turn it into reality, the first objective evidence evaluating the impact of tablets in the hospital, the crossroads of social media and adverse drug effects, and ways virtual care is impacting healthcare today.
This insightful article from guest columnist Craig Monsen, MS, goes over the basic tenets of how to transform your healthcare related app idea into a fully functional iPhone/Android app.
This first part of the series goes over things like programming languages, meeting the right people, and having the tenacity to push forward. Curious about how you can design an app?
Check out the full article for more info.
Unless you have been living under a rock, you are invariably aware that a new version of Apple’s iPad has been released.
This third-generation model brings an improved, HD, screen which promises to further immerse the user in the apple experience. This has major implications for the healthcare industry, and in this article we discuss all the potential.
If you want to see how the convergence of technology and healthcare is occurring, check out our full coverage.
There certainly isn’t a shortage of new exciting features added to the new iPad, and one of the key features is the inclusion of Bluetooth 4.0.
This in-depth article discusses how the new Bluetooth standard has implications for connected medical devices and utilizes low-power technology, which should increase gains in battery efficiency among devices.
To find out more about this exciting technology, see our full analysis.
The healthcare field is fraught with subtitles and nuances that they busy clinician must navigate through daily, and it only gets messier when you start talking social media.
In this interesting article by Dr. Josheph McMenamin, we examine the legal and social implications of social media combined with the constructs of pharmaceutical companies. What do these companies do when they learn about adverse drug effects through social media like Facebook and Twitter? To be part of this ongoing discussion, check out our post.
Dr. Satish Misra previously wrote about the experience at Johns Hopkins of deploying iPads to clinical staff.
Here he discusses how the University of Chicago, one of the earliest institutions with a large scale tablet program, published the findings of a study to demonstrate, in more concrete terms, the efficiency gains associated with tablets.
Curious as to what the conclusions were? Find out more here.
Finally, Robert L. Smith MD, MS is a guest columnist who discussed the merits of virtual care in a recent article.
With the new communication tools available – Skype, Vidyo, GoToMeeting to start – its finally time for medicine to catch up. Here, Dr. Smith describes how they can be used as an acceptable way to manage patient care, not to mention the huge cost savings that can result from using it.
We look at the various technologies that are available and give our opinion on the matter. To discover what we think and to form your own opinion, check out the full article.